Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD
Clinical trial NCT06839339 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06839339
- Sponsor
- Beijing Anlong Biopharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-18
- Primary completion
- 2026-09-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.